Clinical and molecular aspects of an informative family with neurofibromatosis type 1 and Noonan phenotype

被引:28
|
作者
Stevenson, DA [1 ]
Viskochil, DH [1 ]
Rope, AF [1 ]
Carey, JC [1 ]
机构
[1] Univ Utah, Dept Pediat, Div Med Genet, Salt Lake City, UT 84132 USA
关键词
neurofibromatosis; Noonan syndrome; PTPN11; pulmonic stenosis;
D O I
10.1111/j.1399-0004.2006.00576.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Neurofibromatosis-Noonan syndrome (NFNS) has been described as a unique phenotype, combining manifestations of neurofibromatosis type 1 (NF1) and Noonan syndrome, which are separate syndromes. Potential etiologies of NFNS include a discrete syndrome of distinct etiology, co-segregation of two mutated common genes, variable clinical expressivity of NF1, and/or allelic heterogeneity. We present an informative family with an unusual NF1 mutation with variable features of NF1 and Noonan syndrome. We hypothesize that an NF1 mutant allele can lead to diagnostic manifestations of Noonan syndrome, supporting the hypothesis that NF1 allelic heterogeneity causes NFNS.
引用
收藏
页码:246 / 253
页数:8
相关论文
共 50 条
  • [1] Neurofibromatosis Noonan phenotype: A variable feature of type 1 neurofibromatosis
    Colley, A
    Donnai, D
    Evans, DGR
    CLINICAL GENETICS, 1996, 49 (02) : 59 - 64
  • [2] Exclusion of allelism of Noonan syndrome and neurofibromatosis-type 1 in a large family with Noonan syndrome neurofibromatosis association
    Bahuau, M
    Flintoff, W
    Assouline, B
    Lyonnet, S
    LeMerrer, M
    Prieur, M
    GuilloudBataille, M
    Feingold, N
    Munnich, A
    Vidaud, M
    Vidaud, D
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1996, 66 (03): : 347 - 355
  • [3] CLINICAL VARIABILITY OF TYPE-1 NEUROFIBROMATOSIS - IS THERE A NEUROFIBROMATOSIS-NOONAN SYNDROME
    STERN, HJ
    SAAL, HM
    LEE, JS
    FAIN, PR
    GOLDGAR, DE
    ROSENBAUM, KN
    BARKER, DF
    JOURNAL OF MEDICAL GENETICS, 1992, 29 (03) : 184 - 187
  • [4] Clinical phenotype and genetics of neurofibromatosis type 1
    Kehrer-Sawatzki, H.
    Mautner, V-F.
    MEDIZINISCHE GENETIK, 2009, 21 (04): : 519 - 530
  • [5] Patient with a neurofibromatosis type 1 mutation but a clinical diagnosis of Noonan syndrome
    Croonen, Ellen A.
    Yntema, Helger G.
    van Minkelen, Rick
    van den Ouweland, Ans M. W.
    van der Burgt, Ineke
    CLINICAL DYSMORPHOLOGY, 2012, 21 (04) : 212 - 214
  • [6] Type I neurofibromatosis. Molecular and clinical aspects
    Schweigerer, L
    HAUTARZT, 1996, 47 (08): : 591 - 598
  • [7] Noonan syndrome and neurofibromatosis type I in a family with a novel mutation in NF1
    Nystrom, A. M.
    Ekvall, S.
    Allanson, J.
    Edeby, C.
    Elinder, M.
    Holmstrom, G.
    Bondeson, M. L.
    Anneren, G.
    CLINICAL GENETICS, 2009, 76 (06) : 524 - 534
  • [8] Neurofibromatosis-Noonan Syndrome (NFNS) - A molecular and clinical study
    Baralle, D
    Mattocks, C
    Lees, M
    ffrench-Constant, C
    Whittaker, J
    JOURNAL OF MEDICAL GENETICS, 2001, 38 : S66 - S66
  • [9] Factors affecting clinical phenotype in children with neurofibromatosis type 1
    Kamis, Sule Caliskan
    Yagci-Kupeli, Begul
    CUKUROVA MEDICAL JOURNAL, 2021, 46 (02): : 646 - 653
  • [10] Noonan Syndrome: Clinical Aspects and Molecular Pathogenesis
    Tartaglia, M.
    Zampino, G.
    Gelb, B. D.
    MOLECULAR SYNDROMOLOGY, 2010, 1 (01) : 2 - 26